About Us

Meet MaveriX

Our team of world class entrepreneurs, cancer scientists, and oncologists are united by a desire to make life better for patients with cancer. With decades of experience in oncology drug discovery and development at world-renowned academic institutions, innovative biotech companies, and big pharma, we’re charting the path forward for novel Conditionally Activated Small Molecule Therapeutics.

Executive Team

Steven Everett 1
John Kendall 2
Chris Bowers 1
Craig Coburn 1
Kim Nearing
Rick Panicucci 2

Founding Team


Board Member


Strategic Advisory Team


Clinical Advisory Board



Our internationally peer-reviewed science was originally funded by Cancer Research UK and licensed from world-renowned academic institutions in the UK and the US:

Image 10
Image 11
Image 12
Image 13